Acquisition Opportunity S2 Genomics was acquired by Precision Cell Systems in September 2025, signaling potential continuity needs and integration opportunities for customers and product lines. Reach out to PCS-to-S2 transitions teams to identify ongoing contracts, support needs, and cross-sell of Singulator systems and downstream workflows.

Series A Momentum Recent $16M Series A funding in early 2024 demonstrates investor confidence and potential for expanded marketing, distribution, and product development. Target growth-focused conversations around new deployments, regional expansion, and enhanced service packages.

GlobalExpansion Past and ongoing geographic expansion including France and Europe distribution partnerships presents openings for channel partnerships, regional service support, and co-marketing initiatives to accelerate adoption in new markets.

AutomationValue Core offering automates tissue processing into single cells or nuclei, a high-value workflow that can be paired with complementary single-cell genomics platforms. Propose bundled solutions with compatible analyzers, data pipelines, or service agreements to lock in multi-vendor collaborations.

StrategicPartners Existing distribution partnerships in Scandinavia, Iberia, and beyond indicate a receptive partner ecosystem. Develop targeted reseller and integration opportunities with labs and CROs seeking scalable automation and standardized protocols to accelerate project timelines.